Next Article in Journal
The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
Next Article in Special Issue
Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy
Previous Article in Journal
SUMO and KSHV Replication
Previous Article in Special Issue
Drug Resistance in Cancer: An Overview
Article Menu

Export Article

Open AccessReview
Cancers 2014, 6(4), 1925-1952; doi:10.3390/cancers6041925

Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA
*
Author to whom correspondence should be addressed.
Received: 31 July 2014 / Revised: 4 September 2014 / Accepted: 11 September 2014 / Published: 29 September 2014
(This article belongs to the Special Issue Cancer Drug Resistance)
View Full-Text   |   Download PDF [1544 KB, uploaded 29 September 2014]   |  

Abstract

The phenomenon of multidrug resistance (MDR) has attenuated the efficacy of anticancer drugs and the possibility of successful cancer chemotherapy. ATP-binding cassette (ABC) transporters play an essential role in mediating MDR in cancer cells by increasing efflux of drugs from cancer cells, hence reducing the intracellular accumulation of chemotherapeutic drugs. Interestingly, small-molecule tyrosine kinase inhibitors (TKIs), such as AST1306, lapatinib, linsitinib, masitinib, motesanib, nilotinib, telatinib and WHI-P154, have been found to have the capability to overcome anticancer drug resistance by inhibiting ABC transporters in recent years. This review will focus on some of the latest and clinical developments with ABC transporters, TKIs and anticancer drug resistance. View Full-Text
Keywords: multidrug resistance; ABC transporters; tyrosine kinase inhibitor; clinical relevance; pharmacogenomics multidrug resistance; ABC transporters; tyrosine kinase inhibitor; clinical relevance; pharmacogenomics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Wang, Y.-J.; Zhang, Y.-K.; Kathawala, R.J.; Chen, Z.-S. Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance. Cancers 2014, 6, 1925-1952.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top